PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
WAL vs. CVS
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Key characteristics


WALCVS
YTD Return41.99%-27.31%
1Y Return91.54%-16.98%
3Y Return (Ann)-5.87%-13.50%
5Y Return (Ann)14.62%-2.92%
10Y Return (Ann)14.71%-2.20%
Sharpe Ratio2.12-0.48
Sortino Ratio2.89-0.44
Omega Ratio1.360.93
Calmar Ratio1.56-0.34
Martin Ratio9.26-0.81
Ulcer Index9.89%20.02%
Daily Std Dev43.13%34.00%
Max Drawdown-92.14%-64.07%
Current Drawdown-19.75%-45.63%

Fundamentals


WALCVS
Market Cap$10.24B$67.99B
EPS$6.47$3.94
PE Ratio14.3713.71
PEG Ratio1.841.79
Total Revenue (TTM)$4.83B$368.28B
Gross Profit (TTM)$4.77B-$12.93B
EBITDA (TTM)$178.40M$12.81B

Correlation

-0.50.00.51.00.3

The correlation between WAL and CVS is 0.34, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Performance

WAL vs. CVS - Performance Comparison

In the year-to-date period, WAL achieves a 41.99% return, which is significantly higher than CVS's -27.31% return. Over the past 10 years, WAL has outperformed CVS with an annualized return of 14.71%, while CVS has yielded a comparatively lower -2.20% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


-10.00%0.00%10.00%20.00%30.00%40.00%50.00%JuneJulyAugustSeptemberOctoberNovember
43.22%
-2.06%
WAL
CVS

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

WAL vs. CVS - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Western Alliance Bancorporation (WAL) and CVS Health Corporation (CVS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


WAL
Sharpe ratio
The chart of Sharpe ratio for WAL, currently valued at 2.12, compared to the broader market-4.00-2.000.002.004.002.12
Sortino ratio
The chart of Sortino ratio for WAL, currently valued at 2.89, compared to the broader market-4.00-2.000.002.004.006.002.89
Omega ratio
The chart of Omega ratio for WAL, currently valued at 1.36, compared to the broader market0.501.001.502.001.36
Calmar ratio
The chart of Calmar ratio for WAL, currently valued at 1.56, compared to the broader market0.002.004.006.001.56
Martin ratio
The chart of Martin ratio for WAL, currently valued at 9.26, compared to the broader market0.0010.0020.0030.009.26
CVS
Sharpe ratio
The chart of Sharpe ratio for CVS, currently valued at -0.50, compared to the broader market-4.00-2.000.002.004.00-0.50
Sortino ratio
The chart of Sortino ratio for CVS, currently valued at -0.48, compared to the broader market-4.00-2.000.002.004.006.00-0.48
Omega ratio
The chart of Omega ratio for CVS, currently valued at 0.93, compared to the broader market0.501.001.502.000.93
Calmar ratio
The chart of Calmar ratio for CVS, currently valued at -0.35, compared to the broader market0.002.004.006.00-0.35
Martin ratio
The chart of Martin ratio for CVS, currently valued at -0.84, compared to the broader market0.0010.0020.0030.00-0.84

WAL vs. CVS - Sharpe Ratio Comparison

The current WAL Sharpe Ratio is 2.12, which is higher than the CVS Sharpe Ratio of -0.48. The chart below compares the historical Sharpe Ratios of WAL and CVS, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00JuneJulyAugustSeptemberOctoberNovember
2.12
-0.50
WAL
CVS

Dividends

WAL vs. CVS - Dividend Comparison

WAL's dividend yield for the trailing twelve months is around 2.02%, less than CVS's 4.83% yield.


TTM20232022202120202019201820172016201520142013
WAL
Western Alliance Bancorporation
2.02%2.20%2.38%1.11%1.67%0.88%0.00%0.00%0.00%0.00%0.00%0.00%
CVS
CVS Health Corporation
4.83%3.06%2.36%1.94%2.93%2.69%3.05%2.76%2.15%1.43%1.14%1.26%

Drawdowns

WAL vs. CVS - Drawdown Comparison

The maximum WAL drawdown since its inception was -92.14%, which is greater than CVS's maximum drawdown of -64.07%. Use the drawdown chart below to compare losses from any high point for WAL and CVS. For additional features, visit the drawdowns tool.


-50.00%-40.00%-30.00%-20.00%JuneJulyAugustSeptemberOctoberNovember
-19.75%
-45.63%
WAL
CVS

Volatility

WAL vs. CVS - Volatility Comparison

Western Alliance Bancorporation (WAL) has a higher volatility of 19.80% compared to CVS Health Corporation (CVS) at 15.94%. This indicates that WAL's price experiences larger fluctuations and is considered to be riskier than CVS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%15.00%20.00%JuneJulyAugustSeptemberOctoberNovember
19.80%
15.94%
WAL
CVS

Financials

WAL vs. CVS - Financials Comparison

This section allows you to compare key financial metrics between Western Alliance Bancorporation and CVS Health Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities



Values in USD except per share items